DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Meliani A, Boisgerault F, Hardet R. , et al.
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration.
Nat Commun 2018;
9 (01) 4098
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.